Relay Therapeutics Competitors and Similar CompaniesClear all
Verastem Oncology's competitors and similar companies include Walvax Biotechnology and CSL.
 Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||
Founding Date | Founding Date 2010 | Founding Date 2001 | Founding Date 1916 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Needham, US HQ Walsrode, DE | Locations Kunming, CN HQ | Locations Parkville, AU HQ King Of Prussia, US |
Employees | Employees 7328% increase | Employees 2,388 | Employees 32,698 |
Valuation ($) | Valuation ($) 144.9 m | Valuation ($) 3.3 b | Valuation ($) 95.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $15.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods $6.5b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit $9.1b (FY, 2025) |
Net income | Net income ($209.5m) (FY, 2025) | Net income ¥125.2m (FY, 2025) | Net income $3.1b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 170m | Total funding raised $ 72.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company
CSL
HQ
Parkville, AU
Employees
32,698
CSL is a biotech company providing life-saving medicines.
View company